S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.04%) $0.927
USD/NOK
(0.26%) $10.87
USD/GBP
(0.08%) $0.793
USD/RUB
(-0.31%) $92.29

Realtime updates for Cidara Therapeutics Inc [CDTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

9.25% $ 0.920

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States...

Stats
Today's Volume 1.47M
Average Volume 525 508
Market Cap 83.37M
EPS $0 ( 2024-03-28 )
Next earnings date ( $-0.100 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.36
ATR14 $0.00500 (0.54%)
Insider Trading
Date Person Action Amount type
2024-03-15 Ward Shane Buy 120 000 Common Stock
2024-03-15 Ward Shane Buy 250 000 Employee Stock Option (right to buy)
2024-03-15 Shah Preetam Buy 108 750 Common Stock
2024-03-15 Shah Preetam Buy 217 500 Employee Stock Option (right to buy)
2024-03-15 Tari Leslie Buy 111 250 Common Stock
INSIDER POWER
89.27
Last 100 transactions
Buy: 7 175 633 | Sell: 576 273

Volume Correlation

Long: 0.22 (neutral)
Short: 0.85 (strong)
Signal:(48.446) Same movement expected

Cidara Therapeutics Inc Correlation

10 Most Positive Correlations
MESA0.902
ATHX0.885
CTIB0.882
IGTA0.876
HLIO0.873
IOBT0.859
XLNX0.857
TITN0.855
KZR0.854
AZYO0.853
10 Most Negative Correlations
NTUS-0.89
DVCR-0.876
OPNT-0.869
JJSF-0.867
SVOK-0.866
LMNX-0.861
PROC-0.856
STAY-0.852
DSPG-0.843
MSON-0.842

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cidara Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.19
( neutral )
The country flag 0.20
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.14
( neutral )

Cidara Therapeutics Inc Financials

Annual 2022
Revenue: $64.29M
Gross Profit: $64.15M (99.78 %)
EPS: $-0.430
Q3 2023
Revenue: $12.72M
Gross Profit: $12.33M (96.96 %)
EPS: $-0.0905
Q2 2023
Revenue: $7.61M
Gross Profit: $7.21M (94.73 %)
EPS: $-0.140
Q1 2023
Revenue: $25.99M
Gross Profit: $25.67M (98.77 %)
EPS: $0.0250

Financial Reports:

No articles found.

Cidara Therapeutics Inc

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators